Investing

Acceleration of RAD204 Phase 1 dose escalation trial

by admin

Radiopharm Theranostics (RAD:AU) has announced Acceleration of RAD204 Phase 1 dose escalation trial

Download the PDF here.

This post appeared first on investingnews.com

Related Posts

Tartisan Nickel Corp. Intersects 24.6 Metres of 0.71%...

CHARBONE presentera a la conference Hydrogen East et...

Cartier Cuts 7.1 g/t Au over 8.0 m...

NevGold Mobilizes Drill To Test Historical Leach Pads...

LaFleur Minerals Inc.Taking Key Steps to Advance Position...

Uranium Supply Behind, Demand Evolving — What’s Next?...